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Objective: Phenylketonuria (PKU) is due to an inability to metabolize the amino acid phenylalanine
(Phe), leading to its accumulation in the brain. Phe levels can be controlled following a protein-free diet,
but cognitive impairments are still present. A number of questions remain to be answered related to which
type of metabolic control is important, the age when it is important, the cognitive functions which are
most affected and, the best tests to use to monitor cognitive health. Method: We investigated the impact
of metabolic control at different ages on cognitive performance in 37 early treated adults with PKU.
Results: (a) Phe variation was as associated to performance as average Phe showing that stable dietary
control is as important as strict control; (b) For some tasks, current and adult Phe were stronger predictors
of performance than childhood or adolescent Phe, showing the importance of a strict diet even in
adulthood; and (c) The relationship between performance and Phe levels varied depending on time and
cognitive domain. For some functions (sustained attention, visuomotor coordination), Phe at the time of
testing was the best predictor. While for other functions (visual attention, executive functions) there was
a diminishing or stable relationship across time. Conclusion: Results show the importance of selecting
the right tasks to monitor outcomes across ages, but also that the impact of bio-chemical disruptions is
different for different functions, at different ages. We show how inherited metabolic diseases offer us a
unique vantage point to inform our understanding of brain development and functioning.
Keywords: PKU, cognitive skills, phenylalanine fluctuations, development, memory and learning
Phenylketonuria (PKU) is an inherited metabolic disease where
an enzyme deficiency results in an inability/reduced ability to
metabolize the amino acid phenylalanine (Phe) into tyrosine. This
deficiency results in an increased concentration of Phe in the blood
and in the brain which, in turn, causes brain abnormality and
cognitive impairment (Blau, van Spronsen, & Levy, 2010). The
toxic effects of Phe can be minimized by a low Phe diet com-
menced at the time of diagnosis, in infancy. However, the diet is
very restricted (Phe is present in most protein foods) and, thus,
unsociable and expensive for health services (protein supplements
have to be used), which results in variable dietary adherence,
especially after adolescence when the toxic effects of Phe are
unclear. This variable adherence is possibly one of the main
reasons why cognitive outcomes are extremely variable in adults
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with PKU (AwPKU) with some individuals performing extremely
well across cognitive domains and others showing significant
impairments (see Palermo et al., 2017). However, robust evidence
of the importance of treatment after adolescence is lacking (see
later for a review) and this has led to inconsistent recommenda-
tions. Since treatment was introduced, the recommendation to
maintain a strict diet has changed from discontinuation at 6 years
old (see Berry et al., 2013) to treatment for life both in the United
States (Vockley et al., 2014) and Europe (MacDonald personal
communication, forthcoming at http://www.espku.org/who-we-are/
european-guidelines), but how strongly diet for life is recom-
mended across clinical centers remains inconsistent. We need
strong evidence of the impact of high-Phe level on cognition to
support clinical recommendations.
A number of studies have highlighted impairments in speed of
processing and in complex executive functions involving planning,
switching, and monitoring (see Moyle, Fox, Arthur, Bynevelt, &
Burnett, 2007; Christ, Huijbregts, de Sonneville, & White, 2010).
We have also documented these impairments in a group of
AwPKU, while, at the same time, reporting normal performance in
other domains (spelling, naming, verbal and visuospatial memory
and learning; see Palermo et al., 2017). However, although it is
clear that levels of Phe impact cognition in children (Waisbren et
al., 2007), their impact in adults is less clear. We have found only
14 studies that have assessed relationships between Phe levels and
cognitive functions in AwPKU, with mixed results (Bik-
Multanowski, Pietrzyk, & Mozrzymas, 2011; Brumm et al., 2004;
Channon, German, Cassina, & Lee, 2004; Channon, Goodman,
Zlotowitz, Mockler, & Lee, 2007; Channon, Mockler, & Lee,
2005; Moyle, Fox, Bynevelt, Arthur, & Burnett, 2007; Nardecchia
et al., 2015; Pietz et al., 1998; Ris, Williams, Hunt, Berry, &
Leslie, 1994; Schmidt et al., 1994; Smith, Klim, Mallozzi, &
Hanley, 1996; Sundermann et al., 2011; ten Hoedt et al., 2011;
Weglage et al., 2013).
Literature Review
Relationships with cognitive functions have been assessed by
contrasting performance when Phe levels are high or low or by
treating Phe as a continuous variable and assessing correlations.
Comparing Effects of High Versus Low Average Phe
Group of PKU participants have been subdivided using arbitrary
cut-offs for average level of Phe at the time of testing, usually above
versus below 1,000 mol/L (Bik-Multanowski et al., 2011; Brumm et
al., 2004; Smith et al., 1996); by comparing off-diet and on-diet
individuals (Channon et al., 2007; Schmidt et al., 1994); or by con-
trasting performance in the same participants after Phe level has been
manipulated through pharmacological intervention (Sundermann et
al., 2011; ten Hoedt et al., 2011). Across these studies (N  7), 64
comparisons were made with different cognitive measures, of which
25% yielded significant results in the expected direction with worse
performance with higher Phe. Significant results, however, were
found in different tasks and cognitive domains by different studies
(e.g., complex executive functions such as the Wisconsin Card Sort-
ing Test, Smith et al., 1996; working memory, Bik-Multanowski et
al., 2011; Channon et al., 2007; inhibitory control, Bik-Multanowski
et al., 2011; Channon et al., 2007; spoken language, Brumm et al.,
2004; and sustained attention, Bik-Multanowski et al., 2011; Schmidt
et al., 1994; ten Hoedt et al., 2011).
Correlations Between Cognitive Performance and
Phe Levels
Other studies (N  8) have looked at associations between
levels of Phe and cognitive performance through correlations.
Most have looked at correlations with current Phe (Brumm et al.,
2004; Channon et al., 2004, 2005, 2007; Moyle, Fox, Bynevelt, et
al., 2007; Pietz et al., 1998; Ris et al., 1994; Smith et al., 1996)
finding significant associations for a subset of tasks (18/87  21%
across studies) and with these tasks tapping different domains
depending on the study (i.e., complex executive functions: Moyle,
Fox, Bynevelt, et al., 2007; Smith et al., 1996; Ris et al., 1994;
working memory: Channon et al., 2004; spoken language: Brumm
et al., 2004; verbal memory: Moyle, Fox, Bynevelt, et al., 2007,
and visual memory: Moyle, Fox, Bynevelt, et al., 2007). Finally, a
few studies (N 5) have also looked at correlations between adult
cognitive performance and historic levels of Phe during childhood
and/or adolescence (Brumm et al., 2004; Channon et al., 2004,
2005, 2007; Weglage et al., 2013). Again, these studies have found
significant correlations for a subset of tasks across different cog-
nitive domains (17/57  29.8%). Comparing the size of correla-
tions obtained with current versus historical Phe levels is not easy
because different studies looked at Phe levels across different time
bands. However, there are no clear differences supporting the idea
that early metabolic control is particularly important in determin-
ing adult performance and yields stronger correlations.
In spite of variability, current results do show that cognitive
performance in AwPKU is related to present and past levels of
Phe. It is unlikely that the 20–30% of significant outcomes are
obtained by chance. Which cognitive functions do or do not show
a relationship with Phe and at which ages, however, remains
unclear. Across the reviewed studies, the impact Phe levels on
cognitive performance has been examined with as many as 87
different tasks across a variety of cognitive domains. This may
seem an impressive number of tasks, but only a few tasks have
been used by each study (with the exception of Brumm et al., 2004,
with a relatively small number of participants: N  20). This
makes it difficult to assess whether associations vary depending on
cognitive domain. We need studies that assess the same functions
in the same participants to properly allow comparisons.
Predictions
One can entertain different hypotheses of how poor metabolic
control may impact on different functions, at different ages. In adults,
there is some indication that executive functions are more affected by
current Phe levels than measures related to speed of processing
(Bik-Multanowski et al., 2011; Channon et al., 2005; Moyle, Fox,
Bynevelt, et al., 2007). A review by Albrecht, Garbade, and Burgard
(2009) showed a diminishing association between Phe levels and
speed of processing from childhood to adulthood. Speed of processing
relies on fast connections between brain areas. It is possible that the
toxic effect of Phe on myelin (see Möller et al., 2003; Moyle, Fox,
Arthur, et al., 2007) causes structural damage, which is relative
insensitive to Phe differences in adulthood. On the contrary, executive
functions and sustained attention may be more sensitive to a reduction
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in dopamine levels caused by high Phe levels (PKU reduces the
amount of endogenous tyrosine and tyrosine is a precursor of dopa-
mine; Burlina et al., 2000; McKean, 1972; Puglisi-Allegra et al.,
2000). There may also be interactions depending on the maturation
time of different functions. For example, functions that mature earli-
er—such as visuospatial functions—may show a stronger effect of
early metabolic control compared to functions maturing later—such
as some executive functions (for differences in maturation rates see,
Best & Miller, 2010; Gogtay et al., 2004; Klingberg, Vaidya, Gabrieli,
Moseley, & Hedehus, 1999)—which may show stronger association
with adolescent Phe. All of these hypotheses need to be verified
through studies where these functions are examined in the same
participants and put in relation with metabolic control at different
ages.
How to identify the best tasks sensitive to high-level of Phe is also
unclear. One may assume that the functions that are most affected by
high blood Phe are those showing larger group impairments (see van
Spronsen, Huijbregts, Bosch, & Leuzzi, 2011, for such an argument).
This, however, may be unwarranted. Group impairments depend on a
function being systematically impaired across individuals. Correla-
tions, instead, depend crucially on variability. If all individuals in the
group are impaired irrespective of current levels of Phe, no correlation
or modest correlations will be seen. Correlations, instead, may be
stronger when performance in the group is heterogeneous because
only the individuals with the highest Phe are impaired, whereas the
others perform normally. This predicts correlations even for functions
where, as a group, AwPKU do not show a significant impairment.
This is particularly important for AwPKU who have largely main-
tained good metabolic control throughout their life. In these groups,
impairments will be subtler and restricted to some cognitive areas
and/or to individuals with worse control.
Plan of Study
Our study wants to assess the predictions outlined above by
testing a group of 37 AwPKU with relatively good metabolic
control (with averages 500 mol/L in childhood; 850 mol/L
in adolescence and adulthood). Cognitive performance and vari-
ability for the same group of PKU participants was described in
Palermo et al. (2017). Metabolic control at different ages was
available through extensive historic records, allowing us to com-
pare effects in childhood (10 years), adolescence (11–17 years),
and adulthood, as well as at time of testing, on cognitive perfor-
mance in adulthood. We will assess the relationships both by
dividing our participants into groups defined by metabolic control
(better and worse) and by carrying out correlations with continu-
ous measures of metabolic controls.
As in previous studies, we have measured mean Phe levels by
averaging yearly median levels within a time period. In addition, Phe
fluctuations were measured by averaging yearly standard deviations.
Recent evidence from children studies suggest that variability in Phe
levels is equally important (for effect on IQ, see Burgard et al., 1996;
Hood, Grange, Christ, Steiner, & White, 2014; Vilaseca et al., 2010;
for effect on executive functions, see Arnold et al., 1998; Hood et al.,
2014; for a review see Cleary et al., 2013).
We have assessed cognitive performance across a number of
cognitive domains including visuospatial attention, visuomotor
coordination, complex executive functions, inhibitory control,
short-term memory (STM), sustained attention, orthographic pro-
cessing, spoken language, verbal memory and learning, and visual
memory and learning. For tasks of visuospatial attention, picture
naming and word reading both accuracy and speed measures were
taken. We assessed correlations with measures of orthographic
processing (usually not reported in the literature) because they are
highly affected by education and socioeconomic status. Correla-
tions between Phe and cognitive measures may be spuriously
mediated by socioeconomic variables, which may be associated
with both better cognitive performance and better dietary control.
If correlations with orthographic proficiency are not present, this
will strengthen our confidence that cognitive performance is truly
affected by Phe levels.
Results will provide helpful information to (a) justify recom-
mendations to maintain treatment for life; (b) identify best mea-
sures to monitor cognitive outcomes depending on dietary control
and developmental age; and (c) reach a better understanding of the
neurophysiological basis of this disease.
Method
Participants and Procedure
Thirty-seven early treated participants with classical PKU were
recruited from a pool of 88 individuals followed by the Department of
Inherited Metabolic Disorders at Queen Elisabeth Hospital, in Bir-
mingham who had been continuously treated with a low-Phe diet
since diagnosis in infancy and were still contactable. All individuals
who responded to the invitation were tested (N  37). At the time of
testing seven participants were on an unrestricted diet and 30 on a
low-protein diet. The PKU participants were compared to a group of
30 healthy control participants recruited for the purpose of this study.
The control group was matched to the PKU group for age, gender, and
educational status (see Palermo et al., 2017, for further details). Data
on historical Phe levels were obtained from the PKU database at the
Clinical Chemistry Department at Birmingham Children Hospital.
Diagnosis was through newborn screening conducted at 5–7 days
after birth. Demographic and Phe levels across the life span are
reported in Table 1.
Participants were tested in a quiet room in two separate testing
sessions, each lasting about 3 hours. The average interval between
testing session was 37 days (SD  43). Blood Phe concentrations
were measured prior to each testing session; values were then
averaged to determine current Phe level. The research was ap-
proved by the NHS and Aston University Ethics committees. All
participants gave voluntary informed consent to take part. All
efforts were made to administer all tasks to all participants, but
some data points were unavailable due to some PKU participants
(n  6) failing to attend a second appointment and some technical
errors resulting in some missing data for two participants.
Our sample was divided into two subgroups on the basis of
average Phe level from 17 years of age to present 650 ver-
sus 950 mol/L. These valued were selected because they al-
lowed us to divide our sample in two equal groups (N  14 and
14), while, at the same time, including in the group with good
control individuals with values close to current guidelines.
Phe levels in adulthood are strongly correlated with levels at the
time of testing (current Phe) and with adolescent measures, but less
with childhood measures (see Table 2).
244 ROMANI ET AL.
Tasks
As common practice, we used several tasks within each cogni-
tive domain to reduce nondomain task-related variance. Our tasks
were classified according to their primary assessment focus, but a
degree of arbitrariness was unavoidable. For example, tasks like
the digit symbol and the similarity subtest of the WASI are
complex tasks that could have been classified among complex
executive functions rather than within visuomotor coordination
and language processing, respectively, as in this study.
IQ was measured using the Wechsler Abbreviated Scale of
Intelligence (WASI; Wechsler, 1999), which includes the follow-
ing subtests: Vocabulary, Block Design, Similarities, and Matrix
Reasoning. In addition, participants were given an extensive neu-
ropsychological battery including 28 different tasks providing 36
cognitive measures. Our results and measures tapped eight differ-
ent cognitive domains.
Visuospatial attention. This included measures from six
tasks: (a) simple detection—press a response button as soon as a
ladybug appeared on the screen; (b) choice reaction time—press
either a left or right response key consistent with the direction of
an arrow centrally presented; (c) detection with distractors—press
a button whenever a ladybug appeared on the screen alone or with
a green bug; (d) opposite detection with distractors—press a button
whenever a green bug appeared on the screen alone or with a
ladybug; (e) feature search—detect a target among distractors not
sharing features by pressing a “yes” or “no” button (e.g., a red
ladybug among green bugs); and (f) conjoined search—Detect a
target among distractors sharing features (e.g., red ladybug among
red bugs and green ladybugs). Both reaction time (RT) and accu-
racy measures (error rates) were taken.
Visual memory and learning. This included measures from
two tasks: (a) delayed matching to sample—recognize a previously
seen pattern among distractors and b) paired associates visual
learning—learn to associate objects with locations.
Visuomotor coordination. This included measures from two
tasks: (a) grooved pegboard test—put pegs into the holes of a
board using only one hand as quickly as possible and (b) digit
symbol task—fill as many boxes as possible with symbols corre-
sponding with numbers in 90 s.
Complex executive functions. This included measures from
four tasks that, to be completed, involve a number of complex
functions including planning, flexibility, and abstract thinking as well
as to some more specific functions (working memory/STM, sustained
attention, inhibitory control that we examined separately, see below;
see also Miyake et al., 2000): (a) The Wisconsin Card Sorting Test-64
Card Version—discover the rules to match cards from a deck with
four reference cards according to shape, number and color using
feedback. Flexibility is required when the sorting rule is changed
unknown to the participant and the new rule has to be discovered.
Each incorrectly matched card was counted as an error. As a general
score, we considered the total number of errors made by a participant
(maximum number of errors  64). (b) Difference in speed between
Trail Making Test B-A (A involves connecting circles containing
numbers in ascending order as quickly as possible; B also involves
connecting circles in ascending order but alternating between number
and letters). Only speed measures were taken because errors are rare.
(c) Verbal (semantic) fluency—generate as many names of animals
as possible in 1 min of time. This requires planning an efficient search
through the lexicon. (d) The Tower of Hanoi puzzle—move a number
of rings of different sizes across three pegs to form a tower on the last
peg following specific constraints. Our score is based on the percent-
age of solved trials of different complexity (three, four, and five
rings).
Inhibitory control. This included measures from two tasks: (a)
Stroop interference—difference in RTs and errors between reporting
the ink color of words where the color of the ink was incongruent with
the meaning of the word (red written with yellow ink), or congruent
(red written with red ink). (b) Semantic interference—differences in
naming RTs and errors between the first and the last item in a series
of semantically related pictures. A number of studies have demon-
strated reliable differences due to a building up of interference from
semantic competitors (see original study by Howard, Nickels,
Coltheart, & Cole-Virtue, 2006). One hundred sixty-five pictures
were presented one at time on a computer screen and participants
were instructed to say the name as soon as possible. One hundred
Table 2
Correlations Between Phe Blood Concentrations (Phe Average
and Phe Variation) at Different Ages
Variable 1 2 3 4 5 6 7 8 9
Phe average
1. 1–10 years —
2. 11–16 years .65 —
3. 17 .47 .79 —
4. Lifetime .76 .81 .77 —
5. Current .23 .55 .76 .48 —
Phe variation
6. 1–10 years .66 .66 .58 .68 .42 —
7. 11–16 years .07 .28 .37 .08 .28 .73 —
8. 17 .14 .41 .32 .28 .26 .49 .61 —
9. Lifetime .21 .44 .43 .19 .34 .92 .90 .72 —
 p  .05 (2-tails).  p  .01 (2-tails).
Table 1
Demographic Information and Metabolic Control in
Phenylketonuria Participants
Variable M SD Range
Age 27.5 7.3 18–41
Education years 14.4 1.9 11–18
Gender (M/F) 13//24
Childhood (Mean N obs.  197; SD  165)
Phe average 432 243 180–1298
Phe variation 205 63 97–393
Adolescence (Mean N obs.  77; SD  70)
Phe average 721 340 125–1420
Phe variation 157 58 28–284
Adulthood (Mean N obs.  65; SD  74)
Phe average 802 324 188–1465
Phe variation 137 68 22–433
Lifetime (Mean N obs.  340; SD  241)
Phe average 634 291 200–1188
Phe variation 164 58 57–324
Current Phe 720 343 65–1465
Note. Childhood 0–10 years old; adolescence: 11–16 years old; Adult-
hood  17; N obs.  average N of measures for each participant in each
time band; Phe average  average of median of yearly values; Phe
variation  SD of yearly values; Current Phe  Phe at time of testing.
Blood Phe measured in mol/L.
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twenty pictures belonged to 24 different semantic categories (five
items in each category) and the remaining 45 were fillers. The number
of pictures between successive members of the same category varied
from two to eight. RTs were recorded via a voice-key. Previous
results have shown that both RTs and errors progressively increase
with the ordinal position in a set of semantically related pictures
(Howard et al., 2006; Oppenheim, Dell, & Schwartz, 2007). Differ-
ences in accuracy and RT between the first and last exemplar of a set
were taken as an index of the difficulty in controlling lexical semantic
interference.
STM/working memory. This included measures from three
tasks: (a) digit span—repeat a sequence of digits spoken by the
examiner, soon after presentation; (b) nonword repetition—repeat
a sequence of nonwords spoken by the examiner, soon after
presentation; and (c) the Corsi block tapping test—the examiner
taps a sequence of blocks and the participant has to reproduce the
sequence in the same order.
Sustained attention. Percentage correct from the rapid vi-
sual information processing task—in a continuous series of
numbers, detect three target sequences of three digits by press-
ing the response key when the last number of the sequence
appears on the screen. To minimize the need of STM the written
target sequences were kept in view of the participants.
Orthographic language. This involved measures from five
tasks: (a and b) word and nonword reading—read as fast as possible
an English or a made up word and both RT and accuracy measures
(error rates) were taken; (b) spelling—spell words/nonwords to dic-
tation; (d) phoneme deletion—delete a sound from a word (e.g.,
powder; /d/ power); (e) spoonerisms—exchange the initial sounds
of two words to produce two different words (e.g., bad-sin sad-bin).
These last two tasks were included because performance shows strong
correlations with orthographic skills (Landerl, Wimmer, & Frith,
1997; Romani, Tsouknida, & Olson, 2015).
Spoken language. This included measures from four tasks:
(a) picture naming—name a picture as fast as possible; (b) color
naming—name as fast as possible the ink color of three X’s or
colored words; only the congruent condition is considered here,
where the color of the ink matched the meaning of the word, for
example, red written with red ink. Both RT and accuracy measures
(error rates) were taken; (c) similarities from the WASI—describe
how similar in meaning two words are; and (d) vocabulary from
the WASI—define a word.
Verbal Memory and learning. This included measures from
two tasks: The Rey Auditory Verbal Learning Test (learning,
immediate recall and delayed recall of a list of 15 words; Schmidt,
1996) and paired associates verbal learning (learning the associa-
tion between a made-up word and the picture of an object or
animal). 9 pairings with 5 learning trials.
Analyses
When different measures were available for a cognitive domain,
we aggregated results by averaging z scores. Accuracy and speed
measures were similarly averaged. Z scores were calculated in
terms of standard deviations from the control group. Higher z
scores always reflect worse performance. We report both average
z scores and % of impaired cognitive scores out of all scores
computed. This second summary measure is important because
PKU participants may not show an overall level of performance
very different from controls, but still show deficits in a significant
number of tasks.
Results
Overall group differences by cognitive domains are presented in
Table 3. AwPKU were significantly impaired compared to controls
in most cognitive domains with the exception of inhibitory control
and memory and learning. The impairment in visuomotor coordi-
nation was particularly severe. For more details on group perfor-
mance on individual tasks, see Palermo et al. (2017). Group
impairments were evident both in terms of overall z score and
percent of impaired scores.
Differences Between Individuals With Good Versus
Poor Control
Demographic and metabolic information for the two groups, their
IQ, and measures of overall cognitive performance are reported in
Table 4. The two groups do not differ in education, but the group with
poorer control is older. The two groups already differ in metabolic
control in childhood, but differences become stronger in adolescence
and adulthood. Importantly, the two groups differ in cognitive per-
formance. The group with higher Phe has a marginally lower IQ, a
Table 3
Full Scale Intelligence Quotient and Average Z Scores on Each
Cognitive Domain for Adults With PKU Compared to Controls
Cognitive domain n M SD
p difference
with controls
Full Scale IQ 37 103.9 14.3 .003
Visuo-spatial attention 37 .5 .7 .005
Visuo motor coordination 37 1.1 1.6 .001
Complex EF 37 .8 1.2 .002
Inhibitory control 31 .2 .7 .12
Short-term memory 37 .6 .9 .005
Sustained attention 37 .6 1.3 .03
Orthographic processing 35 .5 1.2 .04
Spoken language 37 .7 1.0 .001
Verbal memory and learning 37 .0 .9 .88
Visuo-spatial memory and learn. 31 .5 1.3 .06
Overall z scores 37 .5 .7 .001
% of impaired scores (Z score 2) 37 13.2 15.1 .001
Note. Results are presented as phenylketonuria (PKU Z) scores from the
control group. To facilitate interpretation, for all scores, higher Z-score
reflect worse performance. Visuo-spatial attention  Reaction time (RT)
and accuracy in Simple Detection, Choice Reaction Time, Detection with
Distractors, Feature Search, Conjoined Search. Visuo-motor coordina-
tion  Grooved Pegboard Test, Digit symbol. Complex executive func-
tions (EF)  The Wisconsin Card Sorting Test-64 Card Version score,
Tower of Hanoi scores; Semantic fluency, Trail Making B-A. Inhibitory
controls  Stroop interference effect; Semantic interference effects (both
RTs and accuracy). Short-term memory Digit Span, Nonword repetition,
Corsi Span. Sustained attention  Rapid Visual Information Processing.
Orthographic language RT and accuracy in words and nonword reading,
accuracy in word and nonword spelling, phoneme deletions, and spooner-
isms. Spoken language  RT and accuracy in picture naming and color
naming, Vocabulary Wechsler Abbreviated Scale of Intelligence (WASI),
and Similarities WASI. Verbal memory and learning  The Rey Auditory
Verbal Learning Test and Paired Associates Verbal Learning. 10. Visuo-
spatial memory and learning  Delayed Matching to Sample and Paired
Associates Visual Learning.
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significantly higher overall z score, and a significantly higher percent-
age of impaired scores (2 z scores from control group). Differences
between the low-Phe group and the control group were modest but
remained significant, IQ: t(1,42)  1.98; p  .054; overall z scores:
t(1,42)  2.7; p  .01; % of impaired measures: t(1,42)  2.5;
p  .02.
Results by cognitive domain are shown in Figure 1. In all
domains, except inhibitory control, the lower-Phe group performed
better than the higher-Phe group. Differences reached significance
for visuospatial attention, t(1,26)  2.1; p  .05; visuomotor
coordination, t(1,26)  2.3; p  .05; visuospatial memory and
learning, t(1,26)  2.7; p  .01; and verbal memory and learn-
Table 4
Demographic Information, Metabolic Control, and General Cognitive Performance for Adult
Phenylketonuria Participants With Good vs. Poor Phe Control (650 vs. 950 mol/L Phe
Average)
Variable
Lower-Phe
(n  14)
Higher-Phe
(n  14)
Higher vs. lower t test
and p valueM SD M SD
Age 23.7 6.8 30.5 6.9 t(1.26)  2.6; p  .01
Education 14.2 1.8 13.7 1.7 t(1.25)  .2; p  .45
Gender (M/F) 5/9 5/9
Childhood
Phe average 323 116 494 219 t(1.22)  2.5; p  .02
Phe variation 173 46 246 65 t(1.22)  3.2; p  .004
Mean N obs. per participant 284 149 152 155 t(1.26)  2.3; p  .03
Adolescence
Phe average 432 234 964 269 t(1.23)  5.3; p  .001
Phe variation 142 43 195 51 t(1.23)  2.8; p  .01
Mean N obs. per participant 106 78 73 66 t(1.26)  1.2; p  .24
Adulthood
Phe average 461 135 1140 135 t(1.26)  13.3; p  .001
Phe variation 127 40 165 93 t(1.26)  1.4; p  .16
Mean N obs. per participant 73 72 67 89 t(1.26)  .2; p  .85
Lifetime
Phe average 536 182 823 162 t(1.26)  4.4; p  .001
Phe variation 145 41 197 59 t(1.26)  2.7; p  .01
Mean N obs. per participant 463 244 292 222 t(1.26)  1.9; p  .06
Current Phe 457 271 957 294 t(1.24)  4.5; p  .001
Full Scale IQ 106.9 10.6 96.4 16.6 t(1.26)  2.0; p  .06
Overall z score .3 .3 1.0 .9 t(1.26)  2.8; p  .009
% of impaired scores (Z score  2) 7.3 5.6 22.5 20.3 t(1.26)  2.7; p  .01
Note. Childhood  0–10 years old; adolescence: 11–16 years old; Adulthood  17; N obs.  average N of
measures for each participant in each time band; Phe average  average of median of yearly values; Phe
variation  SD of yearly values; Current Phe  Phe at time of testing.
Figure 1. Comparison of cognitive abilities in lower- and higher-Phe phenylketonuria groups. Results are in
z scores from the control group. Higher z scores always indicate worse performance. The asterisks on the
lower-Phe group indicate a significant difference with controls; the asterisks on the higher-Phe group refer to a
significant difference with the lower-Phe groups. RT  reaction time.  p  0.05.  p  0.01. See the online
article for the color version of this figure.
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ing, t(1,20)  2.4; p  .05. All these differences remained
significant when we covaried number of Phe specimen which
differed between groups. Covarying age, differences between
groups remained significant for visuomotor coordination,
t(1,25)  5.2; p  .03, and visuospatial memory and learning
scores, t(1,25)  4.2; p  .05, whereas differences in verbal
memory and learning, t(1,19)  3.9; p  .06, approached signif-
icance. Overall, the lower-Phe group performed very close to the
controls even if significant differences remained across most do-
mains.
Correlations Between Metabolic and
Cognitive Variables
Table 5 reports Pearson’s R correlations between performance
in different cognitive domains obtained in adulthood and contin-
uous measures of metabolic control from different time bands, in
terms of (a) blood Phe averages, (b) blood Phe fluctuations, and (c)
an overall measure of metabolic control which combined average
and fluctuations using within group z-scores. For ease of interpre-
tation, for all tasks, we have reported as positive those correlations
showing worse performance with higher the Phe (e.g., a correlation
between high Phe and low IQ is reported as positive as well as a
correlation between high Phe and slow RTs). Correlations for
individual tasks are shown in Figure 2.
Differences between domains. Not all correlations were sig-
nificant (in Table 5 considering both correlations with Phe aver-
ages and Phe fluctuations: 43/99  43% are significant). It is
important to note, however, that nonsignificant correlations con-
centrate on a few domains. There are no significant correlations
with inhibitory control, STM, and orthographic language and
correlations with spoken language are limited (no correlations with
Phe average, but correlations with Phe fluctuation). In all other
domains, the great majority of correlations were significant across
different metabolic measures (Phe averages and Phe SDs), with
measures taken at different times, and with good consistency
across individual tasks. This makes it very unlikely that positive
results were obtained by chance. For example, Figure 2 shows that
the number of positive correlations for most cognitive domains is
much higher than would be expected by chance when an equal
number of associations should be positive and negative: for visu-
ospatial attention: 40/45 (2  16.1; p  .001); memory and
learning: 33/35 (2  17.2; p  .001); visuomotor coordination:
10/10 (2  6.7; p  .01); sustained attention: 5/5 (2  3.4; p 
.06); complex executive functions: 20/20 (2  13.3; p  .001).
Instead, as would be expected by chance, a similar number of
positive and negative correlations are seen for orthographic lan-
guage (positive: 22/40; 2  0.2; p  .65), spoken language
(positive 17/30, 2  0.3; p  .60), STM, and inhibitory control
(positive 15/35; 2  0.4; p  .55). It is to be noted that cognitive
domains with stronger associations with metabolic control are not
necessarily those that are more impaired. There are strong corre-
lations between Phe measures and tasks tapping memory and
learning even though there were no group impairments in this
domain.
We have also examined if effects of metabolic control were
particularly evident for measures of speed of processing. Consis-
tent with results from other studies, our adult PKU group was
systematically impaired in speed of processing across domains
(see Palermo et al., 2017). Comparing speed and accuracy mea-
sures is challenging. Within tasks, there may be speed–accuracy
trade-offs with accuracy being at ceiling; between tasks, compar-
isons are more difficult. Still, if Phe levels mainly influenced speed
of processing, differences between speed and accuracy measures
should be observed across tasks. Figure 3 shows, as an example,
Table 5
Correlations Between Performance in Different Cognitive Domains and Measures of Metabolic Control
Variable FSIQ
Visual
attention
Visuo-motor
coord.
Complex
EF
Inhibitory
control STM
Sustained
attention
Orthogr.
language
Spoken
language
Verbal
M&L
Visuo-spatial
M&L
Phe average
Childhood .12 .40 .19 .21 .10 .03 .01 .09 .20 .08 .34
Adolescence .28 .29 .34 .40 .04 .03 .24 .04 .26 .35 .56
Adulthood .33 .38 .39 .26 .05 .05 .33 .21 .28 .47 .48
Lifetime .20 .39 .35 .27 .22 .02 .18 .14 .27 .30 .40
Current .36 .29 .47 .30 .05 .14 .49 .08 .28 .67 .39
Phe variation
Childhood .49 .37 .49 .49 .14 .27 .15 .03 .43 .46 .60
Adolescence .56 .23 .49 .42 .33 .27 .29 .22 .51 .41 .43
Adulthood .42 .16 .46 .32 .20 .22 .40 .06 .53 .03 .36
Lifetime .59 .24 .50 .41 .13 .27 .33 .13 .48 .45 .52
Phe average  variation
Childhood .36 .23 .22 .29 .22 .14 .07 .04 .29 .24 .39
Adolescence .48 .33 .48 .50 .11 .14 .34 .10 .43 .48 .62
Adulthood .47 .33 .52 .35 .07 .17 .45 .20 .50 .37 .52
Lifetime .51 .40 .55 .44 .23 .19 .33 .16 .48 .49 .59
Note. Childhood  0–10 years old; Adolescence  11–16 years old; Adulthood  17; Phe average  average of median of yearly values; Phe
variation  Average SD of yearly values; Current Phe  Phe at time of testing; FSIQ  Full Scale IQ; EF  executive functions; STM  short-term
memory. For the tasks included in each cognitive domain see Table 2 footnote. The number of phenylketonuria participants is slightly different across tests
(see Table 2) and as well as the number of Phe measures available (see Table 1), this means that the same value of r may have different probabilities. N
of correlations  143; N of significant correlations: 66/143  43%; lifetime: 8 /11  73%; current 5/11  46%.
 p  .05.  p  .01.
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correlation between speed and accuracy measures and levels of
current Phe; patterns with other Phe measures are similar. It is
clear, that, if anything, correlations are stronger with accuracy
measures. In fact, consistent with other adult studies (Brumm et
al., 2004; Channon et al., 2005), our results show no significant
associations between speed in visuo-attentional tasks and current
Phe levels. Significant correlations are seen in tasks tapping visuo-
motor coordination and the Trail Making Test B-A (see for similar
results Moyle, Fox, Arthur, et al., 2007). These correlations, how-
ever, may be due to the fact that these tasks tap visuomotor
coordination and complex executive functions, respectively, as
much as to difficulties with speed of processing.
Differences between ages. Table 5 and Figure 2 show that
associations between cognitive performance and metabolic con-
trol are present with measures taken at all ages, indicating that
the history of metabolic control continues to influence perfor-
mance even many years after measures were taken. There are,
however, differences between different tasks and domains. As-
sociations with Phe levels diminish with age in the case of
visuospatial attention. Especially when performance is mea-
sured in terms of speed, correlations with current Phe are very
limited. Similar results have been reported before (Channon et
al., 2005; Moyle, Fox, Bynevelt, et al., 2007). The opposite is
true in the case of tasks tapping memory and learning, visuo-
motor coordination and sustained attention. Here, correlations
with current Phe are generally very high and higher than with
measures taken at previous times. Correlations in other domains
do not show particular trends.
We have statistically analyzed the relative contribution of met-
abolic control at different ages with a series of forward linear
regression analyses with cognitive performance as the dependent
measure and metabolic measures at different ages as predictors.
Different regressions have been carried out with Phe averages and
Phe fluctuations. Results are reported in Table 6. Visuospatial
attention is best predicted by childhood measures (both Phe aver-
age and variation). Visuomotor coordination, sustained attention,
and verbal memory and learning are best predicted by current Phe
levels, but also by Phe fluctuations, respectively, during lifetime,
adulthood, and childhood. Executive functions are best predicted
by adolescent Phe average as well as by childhood Phe fluctuation.
FSIQ is best predicted by life span fluctuations.
Another way to understand whether adult Phe levels indepen-
dently contribute to performance is to assess correlations after the
contribution of Phe levels at an earlier age has been statistically
partialed out. Therefore, we have also carried out correlations
between cognitive measures and adult and current Phe averages/
fluctuations after partialing out corresponding measures in adoles-
cence. A number of correlations remained significant. Most of
Figure 2. Correlations by cognitive domain and metabolic control as average Phe. EF  executive functions;
STM  short-term memory; RVP  Rapid visual information processing. See the online article for the color
version of this figure.
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them involved memory and learning, sustained attention, and the
digit symbol, a complex task that taps, among other skills, visuo-
motor coordination:
1. Phe level 17-to present after partialing out Phe level in
adolescence: Rey Retention: r  .43, p  .02; Digit
symbol: r  .43, p  .02;
2. Phe current after partialing out Phe level in adoles-
cence: Rey Learning: r  .43, p  .02; Rey Retention,
r  .58, p  .01; Rey Delayed Recall, r  .51, p 
.01; Paired associates verbal learning, r  .45, p 
.02; paired associates verbal delayed, r  .50, p  .01;
sustained attention, r  .45, p  .01; choice reaction
time-accuracy, r  .40, p  .02; digit symbol, r  .41,
p  .03;
3. Phe SD 17-to present after partialing out Phe SD in
adolescence: visual search simple RT, r  .38, p 
.05; paired associates visual learning: r  .38, p  .04.
General Discussion
We have carried out our investigation using a much larger set of
tasks than most studies. This has allowed us to obtain three main
findings. First of all, we found strong and widespread correlations
between cognitive performance in adulthood and metabolic control
during the life span, even in a group of relatively well controlled
AwPKU. Metabolic control had an impact both when measured in
terms of average Phe levels and Phe fluctuations. A few studies
have found an impact of Phe fluctuations on IQ and executive
functions in children (for IQ, see Anastasoaie, Kurzius, Forbes, &
Waisbren, 2008; Burgard et al., 1996; Hood et al., 2014; Vilaseca
et al., 2010, for a trend approaching significance; for executive
functions, see Arnold et al., 1998; Hood et al., 2014; but see and
Viau et al., 2011, for negative results). We have demonstrated that
fluctuations at different times during the life span have an impact
on several cognitive measures even in adulthood, reinforcing the
importance of this parameter.
Second, the tasks returning stronger correlations with metabolic
measures were not those showing more significant group impair-
ments. Phe levels are elevated even in individuals with the best
dietary control. It is possible that certain functions (like speed of
processing) show a generalized impairment due to elevated Phe
levels in childhood and across the life span. Instead, it is functions
where the majority of individuals perform well and only a few are
impaired which allow the variability necessary for significant
correlations to emerge. This is important when deciding how to
monitor cognitive health and efficacy of treatment.
Finally, we found that the effect of metabolic control on adult
cognition varied depending on the age when metabolic control was
Figure 2 (continued).
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measured and on the particular cognitive domain examined. Tasks
tapping verbal memory and learning, visuomotor coordination, and
sustained attention were predicted more by recent metabolic con-
trol than by childhood control, so that current Phe level was the
best predictor of performance. Instead, tasks tapping visuospatial
processing and complex executive functions showed stable or
decreasing associations with metabolic control across ages. There
were no correlations with measures of orthographic processing.
This was important. We are interested in a causal relationship
between metabolic control and cognitive performance. However,
both of these measures may be causally related to a third one:
socioeconomic status, with no direct relationship. Better cognition
and better metabolic control could co-occur in individuals with
higher socioeconomic status. However, this hypothesis predicts
that Phe levels will be strongly associated with orthographic pro-
cessing which is a good reflection of socioeconomic status (e.g.,
see Hartas, 2011). The fact that this was not the case reassures us
that correlations truly indicate the influence of metabolic control
on cognition.
The impact of current Phe levels on sustained attention has been
noted before (ten Hoedt et al., 2011; Schmidt et al., 1994), but an
impact on memory and learning has not. In fact, some studies have
reported no significant correlation (Brumm et al., 2004; Smith et
al., 1996; but see Moyle, Fox, Bynevelt, et al., 2007). However, as
we have noted, correlations depend on variability, and no corre-
lation may result when Phe levels are high enough so that perfor-
mance is systematically impaired across a group. It is interesting to
note that in the studies where no correlation was reported (Brumm
et al., 2004; Smith et al., 1996), there were significant group
impairments and the current average Phe level was higher than in
our sample (average Phe 1038; and 1554 mol/L). Instead, in the
study by Moyle, Fox, Bynevelt, et al. (2007) where, like ours, there
was a significant correlation, there was no group impairment
(unfortunately current Phe level was not reported).
There are some plausible reasons why different tasks show asso-
ciations with Phe at different ages. The limited correlation between
adult Phe levels and visuo-spatial speed measures is striking given the
marked and pervasive impairments in our participants. The same
result, however, has been reported by other studies: there is a reduced
speed of processing in AwPKU but no correlations with adult Phe
levels (Channon et al., 2005; Moyle, Fox, Bynevelt, et al., 2007). It is
possible that speed deficits are caused by structural myelin damage
which occurs early in life and/or is consolidated across many years of
suboptimal Phe levels, making it difficult to modulate it through
control in later years (see, Anderson & Leuzzi, 2010). Other func-
tions, such as memory and learning, visuomotor coordination, and
sustained attention, could be more sensitive to adult Phe because of
more plastic effects on dopamine levels. PKU affects dopamine in
two ways (see Lykkelund et al., 1988; Puglisi-Allegra et al., 2000;
Landvogt et al., 2008): first because Phe cannot be converted into
tyrosine which is a precursor of dopamine; and second because both
Phe and tyrosine compete to pass the blood–brain barrier, leading to
high levels of Phe further reducing the availability of tyrosine (see
McKean, 1972; Burlina et al., 2000). Neurons in prefrontal cortex
have a faster firing rate and more rapid dopamine turnover (Bannon et
al., 1981; Tam et al., 1997). Thus, even small decreases in dopamine
could impact functions supported by prefrontal areas, such as sus-
tained attention and visuomotor coordination (for a particular relation
Figure 3. Correlations between current Phe and cognitive performance assessed by speed and accuracy
measures. STM  short-term memory; EF  executive functions. See the online article for the color version of
this figure.
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between dopamine and frontal functions, see Diamond & Baddeley,
1996; Floresco & Magyar, 2006). The importance of dopamine levels
for sustained attention and visuomotor coordination is well estab-
lished (e.g., Nieoullon, 2002), but recent studies have also implicated
the dopaminergic system in memory and learning (Ewell & Leutgeb,
2014; McNamara, Tejero-Cantero, Trouche, Campo-Urriza, & Du-
pret, 2014).
The impact of metabolic control may also depend on when brain
areas are myelinated. Posterior regions supporting visuospatial pro-
cessing will be myelinated first and, thus, an effect of Phe should be
more evident in childhood. Frontal regions are myelinated later and,
thus, an effect on executive functions should be seen in adolescence
and adulthood (Best & Miller, 2010; Gogtay et al., 2004; Klingberg et
al., 1999). This contrast accounts well for our results, which show that
childhood Phe levels are most important for visuospatial attention
whereas adolescence Phe levels are most important for complex
executive functions. Clearly, however, myelin-based and dopamine-
based mechanisms of damage do not need to be mutually exclusive.
Although main myelination occurs at different times for different
brain areas, recent studies have shown that it does not terminate in
adolescence. Far from it, myelin continues to become thicker and
more complete after learning throughout the life span to enable
strengthening of relevant connections (see Wang & Young, 2014;
Zatorre, Fields, & Johansen-Berg, 2012). Thus, high levels of Phe can
impact on the brain in a variety of ways affecting both myelinization
and levels of dopamine, resulting in different effects depending on
type of task and developmental stage.
In conclusion, our results have both clinical implications for the
management of individuals with PKU and theoretical implications
for our understanding of this disease. The literature so far has
provided inconsistent evidence on the type and extent of cognitive
impairments in AwPKU and on the relation with Phe blood con-
centrations. This has resulted in a lack of agreement on how
AwPKU should manage their diet (Hanley, 2004; Hoeks, den
Heijer, & Janssen, 2009; Trefz, Maillot, Motzfeldt, & Schwarz,
2011). Although some clinicians advocate strict adherence to diet
(e.g., ten Hoedt et al., 2011), others have suggested a more per-
missive and flexible approach (e.g., Channon et al., 2007). Our
results are far from conclusive, but add to previous studies in
suggesting that it is important to maintain low blood Phe through
life, not just in childhood, as well as to maintain stable levels and
minimize Phe fluctuations (for a similar conclusion, see also the
meta-analysis of IQ by Lindegren et al., 2012). Our results also
invite caution when selecting tasks to monitor performance. Tasks
where there are more significant and consistent group impairments
may not be the more sensitive to treatment outcomes. The same
caution may apply to other clinical populations. Finally, our results
highlight how the relation between metabolic control and cognitive
functioning is complex and may depend on an interaction between
cognitive domain and developmental stage. They show not only
how effects of Phe change throughout the life span, but also how
these effects may be specific for different cognitive domains.
Our study has a number of limitations (including relative arbitrari-
ness of the cognitive domains, limited number of participants and the
possibility of false positives given the large number of comparisons
carried out). Further studies, should confirm our results. Our study,
however, shows how careful analyses of impairments seen in inher-
ited metabolic disorders like PKU may shed precious light on how
healthy cognition is developed and maintained by the brain. Studies
that investigate the effect of biochemical damage on brain functioning
should complement more traditional studies looking at damage to
structural brain areas. This will allow us to reach a more complete and
integrated understanding of the neurophysiological basis of cognitive
functioning.
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